SCHEMBL16637855

SCHEMBL16637855

CCOC(=O)c1cc(Br)cc(C(F)(F)F)c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.43
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 1/20 0.41
MAPT P10636 1/20 0.41
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39
CA14 Q9ULX7 2/20 0.39
GABRA1 P14867 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7593446 0.83 TSHR (0.44) KDM4EALDH1A1L3MBTL1TSHRMAPT
SCHEMBL31349595 0.83 NOTUM (0.54) NOTUMALDH1A1L3MBTL1MAPTMRGPRX4
SCHEMBL16637355 0.82 KDM4E (0.47) KDM4EALDH1A1L3MBTL1TSHRMAPT
SCHEMBL16638001 0.78 NPC1 (0.48) ALDH1A1L3MBTL1MAPTLMNASMN1; SMN2
SCHEMBL15898866 0.77 LMNA (0.41) NOTUMKDM4EALDH1A1TSHRMAPT
SCHEMBL16647670 0.77 PTPN2 (0.43) NOTUMKDM4EALDH1A1L3MBTL1TSHR
SCHEMBL25111974 0.76 EPRS1 (0.46) NOTUMKDM4EALDH1A1
SCHEMBL30483541 0.76 EPRS1 (0.46) NOTUMKDM4EALDH1A1
SCHEMBL671602 0.74 NOTUM (0.71) NOTUMMAPTLMNACA12CA1
SCHEMBL22207738 0.74 JMJD6 (0.45) KDM4EALDH1A1L3MBTL1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015051496-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2015-04-16 WO disclosed